Cargando…
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
BACKGROUND: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is improving but not benefiting individuals unaware to be infected. To inform screening policies we assessed (1) the hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus antibody (anti-HCV-Ab) p...
Autores principales: | Hahné, Susan JM, Veldhuijzen, Irene K, Wiessing, Lucas, Lim, Tek-Ang, Salminen, Mika, Laar, Marita van de |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716892/ https://www.ncbi.nlm.nih.gov/pubmed/23597411 http://dx.doi.org/10.1186/1471-2334-13-181 |
Ejemplares similares
-
Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
por: Falla, Abby May, et al.
Publicado: (2018) -
A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
por: Lazarus, Jeffrey V, et al.
Publicado: (2014) -
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
por: Wiessing, Lucas, et al.
Publicado: (2014) -
The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
por: Myran, Daniel T, et al.
Publicado: (2018) -
Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
por: HOFSTRAAT, S. H. I., et al.
Publicado: (2017)